Bio Ascend – Developing your personal brand in GI Oncology – OncoDaily
Bio Ascend – Developing your personal brand in GI Oncology / Bio Ascend, cancer, OncoDaily, Oncology
Related Articles
J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer in Japan
Based on the IMpower133 trial, atezolizumab plus carboplatin and etoposide (+CE) is approved as first-line treatment for ES-SCLC. The J-TAIL-2 study evaluated atezolizumab +CE in…
Martha’s rule having ‘transformative effect’, NHS England data shows
Mother of girl who died in 2013 reveals figures on Today programme that are welcomed by national medical director
What medical history can teach us about reports of personality changes after organ transplants
The idea that hearts carry feelings and memories is nothing new.
Seven ways to be a successful remote-working manager
Recent research points to three types of behaviour that can help managers bridge physical distances with staff.
Paper: Phase 3 Randomized Study of Daratumumab Monotherapy Versus Active Monitoring in Patients with High-Risk Smoldering Multiple Myeloma: Primary Results of the Aquila Study
Program: Oral and Poster Abstracts Type: Oral Session: 654. Multiple Myeloma: Pharmacologic Therapies: Refining the Evidence: Randomized Trials in Multiple Myeloma Hematology Disease Topics &…
Paper: Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial
Program: Oral and Poster Abstracts Type: Oral Session: 654. Multiple Myeloma: Pharmacologic Therapies: Refining the Evidence: Randomized Trials in Multiple Myeloma Hematology Disease Topics &…
Cancer screening take ups not back to pre-pandemic levels, charity warns
Cancer Research UK concerned over dwindling participation in breast and cervical cancer screening
Ethics of posthumous scholarly authorship in the sciences – PubMed
Ethics of posthumous scholarly authorship in the sciences
GloRilla gives back to her alma mater Melrose High
GloRilla donated $25,000 for a new media center for her alma mater Melrose High.
AXL-TBK1 driven AKT3 activation promotes metastasis
The pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer is revealed.
